Concepedia

Timothy P. Sheahan

TP

Statistics

Publications

89

Citations

17.5K

H-Index

51

Active since

2003

Affiliations

University of North Carolina at Chapel Hill(Current)

Gilead Sciences (United States)

Rockefeller University

Vanderbilt University Medical Center

University of Washington

Timothy P. Sheahan is an author at University of North Carolina at Chapel Hill specializing in infectious diseases, virology, and life sciences.

ORCID

Publications per year

2003–2024

89

Publications

89

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Timothy P. Sheahan, Amy Sims, Sarah R. Leist et al. · Nature Communications · 2020 · 1.8K citations · Full text

, , +12

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses

Timothy P. Sheahan, Amy Sims, Rachel L. Graham et al. · Science Translational Medicine · 2017 · 1.6K citations · Full text

, , +14

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini, Erica L. Andres, Amy Sims et al. · mBio · 2018 · 1.5K citations · Full text

, , +16

An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

Timothy P. Sheahan, Amy Sims, Shuntai Zhou et al. · Science Translational Medicine · 2020 · 1.2K citations · Full text

, , +17

Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

Lisa E. Gralinski, Timothy P. Sheahan, Thomas E. Morrison et al. · mBio · 2018 · 700 citations · Full text

, , +17

1–5 of 89